Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103834712 | 10383471 | 2 | F | 201402 | 20160726 | 20140814 | 20160729 | EXP | FR-009507513-1408FRA004429 | MERCK | 59.00 | YR | M | Y | 0.00000 | 20160729 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103834712 | 10383471 | 1 | PS | EMEND | APREPITANT | 1 | Oral | UNK | 21549 | CAPSULE | |||||||||
| 103834712 | 10383471 | 2 | SS | MABTHERA | RITUXIMAB | 1 | UNK | 0 | |||||||||||
| 103834712 | 10383471 | 3 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103834712 | 10383471 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103834712 | 10383471 | Gait disturbance | |
| 103834712 | 10383471 | Paraesthesia | |
| 103834712 | 10383471 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103834712 | 10383471 | 1 | 201312 | 0 | ||
| 103834712 | 10383471 | 2 | 201312 | 0 | ||
| 103834712 | 10383471 | 3 | 201312 | 0 |